Previous 10 | Next 10 |
Pressure BioSciences (PBIO) has signed a letter of intent to purchase assets of an internationally-based developer and supplier of organically natural, eco-friendly agrochemicals.The company expect the assets to be accretive, driving significant new revenues and profitability in 2021 and beyo...
Pressure BioSciences Plans to Acquire Assets of Global Eco-Friendly Agrochemical Supplier PBI's Ultra Shear Technology for Nanoemulsion Processing Targets New Generation of High Performance, "Green" Agrochemicals for Worldwide Distribution into Food Production Markets PR New...
Citi analyst Neena Bitritto upgraded Passage Bio (PBIO) to a buy rating from neutral, noting a recent pressure on shares despite a range of potential clinical updates from the company in the next 12 months.The price target of $28 per share, reflects a ~33.8% upside to the close following a ~5...
Pressure BioSciences Ultra Shear Technology Nanoemulsions Platform Targets Revolution in Effectiveness of Therapeutics via Improved Drug Delivery and Dosing Safety PBI Announces Collaboration to Improve and Optimize SinuSys Corp's Lead Sinus Health Product Candidate for Commence...
NEW YORK, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced that the presentations from the December 17th conference are now available for on-demand viewing at LifeSciencesInvestorForum.com. This virtual event showcased live company presentations and inter...
Pressure BioSciences PCT Platform at Forefront in Generating Pivotal Findings by Diverse COVID-19 Research Teams in USA, China, and Europe SOUTH EASTON, Mass. , Dec. 17, 2020 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader...
Pressure BioSciences to Present at Upcoming Life Sciences Investor Forum SOUTH EASTON, Mass. , Dec. 15, 2020 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that the Company will participate in the Life Sciences Investor...
NEW YORK, Dec. 14, 2020 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced the agenda for its quarterly event for public and private companies, investors and industry professionals from around the world. This day-long virtual event will showcase live company presentations and ...
Pressure BioSciences Proposed Acquisition Partner Cannaworx, Inc. Announces December 2020 Launch Date for FDA Registered Immune Booster SOUTH EASTON, Mass. , Dec. 4, 2020 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the d...
Pressure BioSciences, Inc. (PBIO) Q3 2020 Results Conference Call November 17, 2020 04:30 PM ET Company Participants Rick Schumacher - CEO Jeff Peterson - Chairman Conference Call Participants Gary Zwetchkenbaum - Plum Tree Consulting Presentation Operator Greetings, and welcome to Pressure B...
News, Short Squeeze, Breakout and More Instantly...
Pressure BioSciences Inc Company Name:
PBIO Stock Symbol:
OTCMKTS Market:
Pressure BioSciences Inc Website:
Pressure BioSciences (OTCQB: PBIO) , a leading innovator in high-pressure nanotechnology and a pioneer in the development of novel, broadly-enabling, pressure-based instruments and nanoemulsion products and services across global industries, today announced a partnership with Vita-Forte, the larg...
CANTON, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBIO” or the “Company”), a leading innovator in high-pressure nanotechnology and a pioneer in the development of novel, broadly-enabling, pressure-based instruments and nanoemul...
Pressure BioSciences (OTCQB: PBIO) , a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables and specialty process development and testing services across global industries, today announced that it will host a teleconference to update investors an...